CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...